Log In
Print this Print this

trebananib (AMG 386)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionRecombinant Fc-peptide fusion protein (peptibody) targeting angiopoietins
Molecular Target Angiopoietin 1 (ANG1) (ANGPT1) ; Angiopoietin 2 (ANG2) (ANGPT2)
Mechanism of ActionAngiogenesis inhibitor
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today